Alkami Technology, Inc. (ALKT)
Quote, stock score, analyst consensus, and SEC filings, plus insider and Congress trades when there are any.
NasdaqGS · Price as of · Nasdaq Real Time Price
- Profitability5/20
Losing money ($-49.8M over the last four reported quarters), but the top line is growing fast. Revenue over the last four reported quarters was $475.6M, up 31% from $363.1M the year before. Growth this quick earns partial credit; it still has to turn into profit.
- Insider buying vs selling15/20
The last 20 Form 4s show no open-market buys or sells (grants and option exercises don't count either way). Neutral. Separately, 2 new 5%+ stake disclosures (13D/13G) hit in the last 6 months, which is big-money accumulation.
- Dilution and offerings11/15
Share count up 2.7% in a year. Mild dilution.
- Analysts7
- Implied upside+30.2%
- Target range$14.00 to $25.00
- EPS expected$0.20 +56%
- A year ago$0.13
- Revenue expected$133.5M +18%
- Estimate range$0.19 to $0.22
ALKT closed at $15.36 on Oct 27, up 14.7% since Sep 28. Chart read: price below both the 50-day and 200-day moving averages; the 50-day is below the 200-day (downtrend structure); trading at 19% of the 52-week range ($13.37 to $23.67).
Insider buying and selling at Alkami Technology, Inc. (ALKT)
The most recent Form 4 on record for Alkami Technology, Inc. (ALKT) is May 12, 2026, when Atlantic Genpar (BERMUDA), L.p. General, Director, bought $32.9M of stock. An open-market purchase is money the filer chose to put in.
| Insider | Action | Value | Date | Type |
|---|---|---|---|---|
| Atlantic Genpar (BERMUDA), L.p. General · Director | Buy | $32.9M | May 12, 2026 | Strong signal |
| Atlantic Genpar (BERMUDA), L.p. General · Director | Buy | $34.7M | May 4, 2026 | Strong signal |
| ATLANTIC, L.p. General · Director | Buy | $34.7M | May 4, 2026 | Strong signal |
| Atlantic Genpar (BERMUDA), L.p. General · Director | Buy | $50.6M | March 9, 2026 | Strong signal |
| ATLANTIC, L.p. General · Director | Buy | $50.6M | March 9, 2026 | Strong signal |
| Alex Shootman · Chief Executive Officer | Sell | $941,026 | December 9, 2025 | No decision |
| Alex Shootman · Chief Executive Officer | Sell | $1.1M | September 9, 2025 | No decision |
| W Bryan Hill · Chief Financial Officer | Sell | $504,262 | September 2, 2025 | No decision |
SEC filings
| Form | Filed | Description |
|---|---|---|
| SCHEDULE 13D/A | October 16, 2026 | View on EDGAR |
| 4 | October 7, 2026 | FORM 4 |
| 4 | October 7, 2026 | FORM 4 |
| 4 | October 7, 2026 | FORM 4 |
| 4 | October 7, 2026 | FORM 4 |
| 4 | October 7, 2026 | FORM 4 |
| 8-K | October 7, 2026 | 8-K |
| 4 | September 9, 2026 | FORM 4 |
Frequently asked questions
When does ALKT report earnings?
Alkami Technology, Inc. (ALKT) is scheduled to report quarterly results today, after the close. The 7-analyst consensus is $0.20 per share on revenue of $133.5M for the quarter ended September 30, 2026, against $0.13 and $113.0M a year earlier. It has beaten the consensus EPS estimate in 2 of the last four quarters.
What do analysts expect for ALKT?
7 analysts cover Alkami Technology, Inc. (ALKT). No consensus rating has been published. The average price target is $19.86, in a range of $14.00 to $25.00.
Are insiders buying or selling ALKT?
We track Form 4 filings for Alkami Technology, Inc. (ALKT). The activity listed on this page shows 5 open-market purchases and 4 qualifying sales. Each row is labelled Routine when the filer declared a pre-arranged 10b5-1 plan, Tax withholding when shares were sold automatically to cover the tax on a vest, or Own call when neither applies.
Where can I see ALKT SEC filings?
Recent filings are listed on this page, newest first. The latest is a SCHEDULE 13D/A filed October 16, 2026.